1. Home
  2. CCG vs AYTU Comparison

CCG vs AYTU Comparison

Compare CCG & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheche Group Inc.

CCG

Cheche Group Inc.

HOLD

Current Price

$17.11

Market Cap

30.8M

Sector

N/A

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.38

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCG
AYTU
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
27.4M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
CCG
AYTU
Price
$17.11
$2.38
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$350.00
$9.33
AVG Volume (30 Days)
19.7K
31.6K
Earning Date
05-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,632,080.00
Revenue This Year
N/A
N/A
Revenue Next Year
$567.38
$43.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
277.47
52 Week Low
$0.34
$1.65
52 Week High
$17.99
$3.07

Technical Indicators

Market Signals
Indicator
CCG
AYTU
Relative Strength Index (RSI) 67.30 56.52
Support Level $0.65 $2.13
Resistance Level N/A $2.46
Average True Range (ATR) 1.86 0.09
MACD -0.27 0.00
Stochastic Oscillator 70.38 60.71

Price Performance

Historical Comparison
CCG
AYTU

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: